STOCK TITAN

Aadi Bioscience to Report Third Quarter 2024 Results and Corporate Update

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings

Aadi Bioscience (NASDAQ: AADI) has announced it will release its third quarter 2024 financial results and provide corporate updates on Wednesday, November 6, 2024. The company will make this information available on the Investors & News section of their website at aadibio.com.

Aadi Bioscience (NASDAQ: AADI) ha annunciato che rilascerà i suoi risultati finanziari del terzo trimestre 2024 e fornirà aggiornamenti aziendali mercoledì 6 novembre 2024. L'azienda renderà queste informazioni disponibili nella sezione Investitori & News del proprio sito web all'indirizzo aadibio.com.

Aadi Bioscience (NASDAQ: AADI) ha anunciado que publicará sus resultados financieros del tercer trimestre de 2024 y proporcionará actualizaciones corporativas el miércoles 6 de noviembre de 2024. La compañía pondrá esta información a disposición en la sección de Inversores y Noticias de su sitio web en aadibio.com.

Aadi Bioscience (NASDAQ: AADI)는 2024년 3분기 재무 결과를 발표하고 2024년 11월 6일 수요일에 기업 업데이트를 제공할 것이라고 발표했습니다. 이 회사는 이 정보를 자신의 웹사이트 aadibio.com의 투자자 및 뉴스 섹션에서 제공할 것입니다.

Aadi Bioscience (NASDAQ: AADI) a annoncé qu'il publiera ses résultats financiers du troisième trimestre 2024 et fournira des mises à jour sur l'entreprise mercredi 6 novembre 2024. La société mettra ces informations à disposition dans la section Investisseurs & Actualités de son site web à aadibio.com.

Aadi Bioscience (NASDAQ: AADI) hat angekündigt, dass es seine Finanzergebnisse für das dritte Quartal 2024 veröffentlichen und Unternehmensupdates am Mittwoch, den 6. November 2024 bereitstellen wird. Das Unternehmen wird diese Informationen im Bereich Investoren & Nachrichten auf seiner Website aadibio.com zur Verfügung stellen.

Positive
  • None.
Negative
  • None.

LOS ANGELES, Oct. 30, 2024 /PRNewswire/ -- Aadi Bioscience, Inc. (NASDAQ: AADI) today announced that it will report third quarter 2024 financial results and provide recent corporate updates on Wednesday, November 6, 2024. These results will be available under the "Investors & News" page of the Aadi Bioscience website at aadibio.com.

About Aadi Bioscience 

Aadi is a precision oncology company focused on the commercialization of FYARRO® for the treatment of adult patients with locally advanced unresectable or metastatic malignant perivascular epithelioid cell tumor (PEComa). More information on the Company is available on the Aadi website at www.aadibio.com and connect with us on Twitter and LinkedIn.

Contact:
IR@aadibio.com 

(PRNewsfoto/Aadi Bioscience)

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/aadi-bioscience-to-report-third-quarter-2024-results-and-corporate-update-302291958.html

SOURCE Aadi Bioscience

FAQ

When will Aadi Bioscience (AADI) release Q3 2024 earnings?

Aadi Bioscience (AADI) will release its third quarter 2024 financial results on Wednesday, November 6, 2024.

Where can I find Aadi Bioscience (AADI) Q3 2024 earnings report?

Aadi Bioscience's Q3 2024 earnings report will be available under the Investors & News section of their website at aadibio.com.

Aadi Bioscience, Inc.

NASDAQ:AADI

AADI Rankings

AADI Latest News

AADI Stock Data

55.71M
22.17M
9.96%
49.17%
1.14%
Biotechnology
Pharmaceutical Preparations
Link
United States of America
PACIFIC PALISADES